effects [qlco]
Raloxifene [orch, phsu]
Lipid [lipd]
Lipoprotein [aapp, bacs]
Level [qlco]
postmenopausal [tmco]
Women [popg]
Hypertriglyceridaemia [fndg]
This [euka]
Post [tmco]
Analysis [lbpr]
Report [inpr]
effects [qlco]
Raloxifene [orch, phsu]
Lipids [lipd]
Lipoproteins [aapp, bacs]
Women [popg]
Normal [qlco]
mg dl [qnco]
High [qlco]
mg dl [qnco]
Triglyceride level [lbtr]
Of [spco]
Multiple [qnco]
Outcome [ftcn]
Raloxifene [orch, phsu]
Evaluation [ftcn]
Trial [resa]
Triglyceride [bacs, lipd]
subgroups [virs]
Raloxifene [orch, phsu]
Improved [qlco]
Low Density Lipoprotein Cholesterol [bacs, strd]
Total Cholesterol [lbpr]
Non [ftcn]
High Density Lipoprotein Cholesterol [bacs, lipd]
Apolipoprotein B [aapp, bacs]
Apolipoprotein A-I [aapp, bacs]
Fibrinogen [aapp, bacs, phsu]
Compared [acty]
placebo [topp]
P NOS [aapp, imft]
Raloxifene [orch, phsu]
treatment [ftcn]
Women [popg]
high triglycerides [fndg]
experience [menp]
Equal [qlco]
More [ftcn]
Robust [qlco]
reduction [npop]
Cholesterol [bacs, strd]
Lipoprotein [aapp, bacs]
Parameters [fndg]
Ratios [qnco]
Total Cholesterol [lbpr]
High Density Lipoprotein Cholesterol [bacs, lipd]
Non [ftcn]
High Density Lipoprotein Cholesterol [bacs, lipd]
High Density Lipoprotein Cholesterol [bacs, lipd]
Observed [ftcn]
Women [popg]
normal triglycerides [fndg]
P NOS [aapp, imft]
Mean [qnco]
Levels [qlco]
Low Density Lipoprotein Cholesterol [bacs, strd]
Apolipoprotein B [aapp, bacs]
Reduced [qlco]
Women [popg]
high triglycerides [fndg]
Women [popg]
normal triglycerides [fndg]
findings [ftcn]
Further [spco]
Raloxifene [orch, phsu]
Concentrations [menp]
Cholesterol [bacs, strd]
Beta-lipoprotein [aapp, bacs, lipd]
subgroup [virs]
Women [popg]
high triglycerides [fndg]
Elevated [qlco]
CARDIOVASCULAR [bdsy]
Risk [qlco]
APPEAR [qlco]
To [qlco]
Equal [qlco]
Not [ftcn]
Overall [inpr]
Effect [qlco]
Lipid [lipd]
Lipoprotein [aapp, bacs]
lowering [spco]
Raloxifene [orch, phsu]
[c] [qnco]
Rights [qlco]
Reserve [acty]
